1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Aseptic Sampling Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of communicable diseases and pandemics
5.1.1.2. Need for drug safety attributed to strict government regulations
5.1.1.3. Growing adoption of single-use aseptic sampling systems
5.1.2. Restraints
5.1.2.1. Concerns associated with extractable and leachable
5.1.3. Opportunities
5.1.3.1. Robust research and development activities to introduce advanced products
5.1.3.2. Expiry of patented drugs and emerging emphasis on personalized medicines
5.1.3.3. Advanced role in microbiome analysis and development of the personalized medicines
5.1.4. Challenges
5.1.4.1. Issues with waste disposal and sluggish adoption of advanced technologies in end-user sector
5.2. Market Segmentation Analysis
5.2.1. Type: Proliferation in the use of automated aseptic sampling systems for improved accuracy, repeatability, and contamination control
5.2.2. Technique: High adoption rate of on-line sampling technique for real-time data collection
5.2.3. Component: Preference for single-use assemblies for aseptic sampling processes in pharmaceuticals and biotechnology industries
5.2.4. Application: Use of aseptic sampling in upstream processes for real-time assessment of nutrient levels and pH levels
5.2.5. End User: Research and development (R&D) departments prioritize aseptic sampling to ensure sample integrity for accurate results in research studies
5.3. Market Trend Analysis
5.3.1. Ongoing technological advancement in aseptic sampling supported by the well-established regulatory framework
5.3.2. Expanding pharmaceutical sector and research capabilities across Asia-Pacific and need to aseptic sampling
5.3.3. Rapidly advancing aseptic sampling development and adoption across EMEA
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
5.10. Client Customization
5.10.1. Increasing preference towards single use assemblies
6. Aseptic Sampling Market, by Type
6.1. Introduction
6.2. Automated Aseptic Sampling
6.3. Manual Aseptic Sampling
6.4.1. Accessories
6.4.2. Bags
6.4.3. Bottles
6.4.4. Syringes
7. Aseptic Sampling Market, by Technique
7.1. Introduction
7.2. At-Line Sampling Technique
7.3. Off-Line Sampling Technique
7.4. On-Line Sampling Technique
8. Aseptic Sampling Market, by Component
8.1. Introduction
8.2. Single-use Assemblies
8.3. Steel Valve
9. Aseptic Sampling Market, by Application
9.1. Introduction
9.2. Downstream Processes
9.3. Upstream Processes
10. Aseptic Sampling Market, by End User
10.1. Introduction
10.2. Biotechnology & Pharmaceutical Manufacturers
10.3. Contract Research & Manufacturing Organizations
10.4. Research & Development Departments
11. Americas Aseptic Sampling Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Aseptic Sampling Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Aseptic Sampling Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.2. Market Share Analysis, By Key Player
14.3. Competitive Scenario Analysis, By Key Player
14.3.1. Merger & Acquisition
14.3.1.1. Sartorius To Acquire Polyplus
14.3.1.2. MilliporeSigma Announces Acquisition of MAST Platform from Lonza, an Automated Bioreactor Sampling System to Advance BioProcessing Capabilities
14.3.2. Agreement, Collaboration, & Partnership
14.3.2.1. Sartorius Collaborates With RoosterBio to Advance Downstream Purification Processes for the Manufacture of Exosomes
14.3.2.2. Beckman Coulter Life Sciences Partners with Flownamics on Bioprocess Culture Monitoring Solution
14.3.2.3. Tema Sinergie makes aseptic and containment partnership
14.3.2.4. Arzeda Announces Collaboration with W. L. Gore & Associates to Drive Innovation in Materials Research with Designer Proteins
14.3.2.5. Moderna and Thermo Fisher Scientific Announce Long-Term Strategic Collaboration
14.3.3. New Product Launch & Enhancement
14.3.3.1. 908 Devices Unveils New Glucose and Lactate On-Line Device for Bioprocess Monitoring and Control
14.3.3.2. Gea Introduces Pharma Separator Lines Aseptic and Pure For Biopharmaceutical Separation Processes
14.3.3.3. TEMA Sinergie launches automatic aseptic vial filling system
14.3.3.4. Avantor Launches Aseptic Sampling System For Bioprocessing
14.3.4. Award, Recognition, & Expansion
14.3.4.1. Qualitru Sampling Systems Introduces New TruStream7 Septum EU to Help Enhance Food Safety and Quality
15. Competitive Portfolio
15.1. Key Company Profiles
15.1.1. 3M Company
15.1.2. Advanced Microdevices Pvt. Ltd.
15.1.3. Aerre Inox S.r.l.
15.1.4. Avantor, Inc.
15.1.5. bbi-biotech GmbH
15.1.6. Biomatics Technology ApS
15.1.7. bioMérieux SA
15.1.8. Cardinal Health, Inc.
15.1.9. Centec GmbH
15.1.10. Compagnie de Saint-Gobain
15.1.11. Eppendorf SE
15.1.12. Flownamics, Inc.
15.1.13. GE HealthCare Technologies Inc.
15.1.14. GEA Group Aktiengesellschaft
15.1.15. GEMÜ Gebr. Müller Apparatebau GmbH & Co. KG
15.1.16. Hardy Diagnostics
15.1.17. KEOFITT A/S
15.1.18. KIESELMANN GmbH
15.1.19. Merck KGaA
15.1.20. MTC Bio, Inc.
15.1.21. Pall Corporation
15.1.22. Parasol Medical, LLC
15.1.23. PerkinElmer, Inc.
15.1.24. QIAGEN N.V.
15.1.25. QualiTru Sampling Systems
15.1.26. Rattiinox S.r.l.
15.1.27. Sartorius AG
15.1.28. Tema Sinergie S.p.A.
15.1.29. Thermo Fisher Scientific Inc.
15.1.30. Trace Analytics, LLC
15.1.31. W. L. Gore & Associates, Inc.
15.2. Key Product Portfolio
16. Appendix
16.1. Discussion Guide
16.2. License & Pricing
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer